Biolife Solutions Overview
Valuation check: BLFS's P/E ratio is 35.18, above the Healthcare sector average of 25.9.
Get informed when a big investor buys or sells
+ Follow35.18
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, BLFS shows a P/E ratio of 35.18. That is above the Healthcare sector average of 25.9. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 25.9. Biolife Solutions is at 35.18, which is higher that average. That is roughly 35.8% above the sector mean. Use the comparison chart on this page to see how BLFS stacks up against individual peers as well.
Investors watch BLFS's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Biolife Solutions's latest reading is 35.18. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Biolife Solutions's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 35.18) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 25.9, while BLFS is at 35.18. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
